Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
3
Bearish filings
142
Named actors
13
Disclosed $ (bull / bear)
$61.0M / $112.0M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-12 | Chief Executive Officer Lin Yu-Hsin | sold | $40K | SEC ↗ |
| 2026-08-12 | Chief Executive Officer Lin Yu-Hsin | sold | $26K | SEC ↗ |
| 2026-08-12 | Chief Financial Officer Chuang Hao-Yuan | sold | $26K | SEC ↗ |
| 2026-08-12 | Chief Financial Officer Chuang Hao-Yuan | sold | $40K | SEC ↗ |
| 2026-08-12 | Officer, Director (via J.P. Morgan Securities LLC) Hao-Yuan Chuang | filed notice to sell | $16.7M | SEC ↗ |
120 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-12 | CEO, Chairman (via J.P. Morgan Securities LLC) Yu-Hsin Lin | filed notice to sell | $22.5M | SEC ↗ |
| 2026-06-30 | Institution (13F) MAVERICK CAPITAL LTD | reported a new position | $61.0M | — |
| 2026-06-18 | Chief Medical Officer Scholl Hendrik Peter | sold | $14K | SEC ↗ |
| 2026-06-18 | Chief Medical Officer Scholl Hendrik Peter | sold | $707K | SEC ↗ |
| 2026-06-18 | Chief Medical Officer Scholl Hendrik Peter | sold | $14K | SEC ↗ |
| 2026-06-18 | Chief Medical Officer Scholl Hendrik Peter | sold | $175K | SEC ↗ |
| 2026-06-18 | Chief Medical Officer Scholl Hendrik Peter | sold | $542K | SEC ↗ |
| 2026-06-18 | Affiliate (via J.P. Morgan Securities LLC) Dr. Hendrick P. Scholl | filed notice to sell | $1.5M | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $438K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $283K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $150K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $108K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $64K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $14K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $272K | SEC ↗ |
| 2026-06-16 | Chief Medical Officer Scholl Hendrik Peter | sold | $76K | SEC ↗ |
| 2026-06-16 | Affiliate (via J.P. Morgan Securities LLC) Dr. Hendrick P. Scholl | filed notice to sell | $1.4M | SEC ↗ |
| 2026-05-07 | Chief Scientific Officer MATA NATHAN L. | sold | $34K | SEC ↗ |
| 2026-05-07 | Chief Scientific Officer MATA NATHAN L. | sold | $464 | SEC ↗ |
| 2026-05-07 | Chief Scientific Officer MATA NATHAN L. | sold | $66K | SEC ↗ |